NDC 82922-001 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-001
- Package NDCs from labels
- 82922-001-01
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoprolol tartrate - Truemed Group LLC | Truemed Group LLC | 2022-08-03 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoprolol Tartrate | METOPROLOL TARTRATE | A-S Medication Solutions | f4e88ecc-2d9b-4bad-97dd-77b1cbb75eb0 | 2024-10-03 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Proficient Rx LP | 5a4969d2-d569-4d2b-b698-092f07bd055a | 2024-10-01 | Warnings, Adverse reactions | W5S57Y3A5L |
| METOPROLOL TARTRATE | METOPROLOL TARTRATE | TRUPHARMA LLC | 92ab5942-823d-43aa-8e7a-56844ab8946f | 2024-09-18 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Bryant Ranch Prepack | 6c7fa479-bd5f-43df-b0ab-8d8a5fd87e13 | 2024-08-27 | Warnings, Adverse reactions | W5S57Y3A5L |
| METOPROLOL TARTRATE | METOPROLOL | Alembic Pharmaceuticals Inc. | 24837d82-0f3f-4482-9af0-31e5f675c30f | 2024-08-22 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | A-S Medication Solutions | 70c2fada-d604-4d0c-9b3c-1f21737a77d7 | 2024-07-23 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | NuCare Pharmaceuticals,Inc. | a2669da1-b712-5fd5-e053-2a95a90a52f3 | 2024-06-20 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | NuCare Pharmaceuticals,Inc. | 8cce6c9a-2457-18cd-e053-2995a90a3af2 | 2024-06-18 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | NuCare Pharmaceuticals,Inc. | 8cf0a64b-1f97-29a2-e053-2a95a90a0afd | 2024-06-18 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | NuCare Pharmaceuticals,Inc. | 813d0b50-26d6-f732-e053-2991aa0ae24a | 2024-06-14 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | NuCare Pharmaceuticals,Inc. | 81f6854e-72fa-83b9-e053-2a91aa0afe01 | 2024-06-14 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | NuCare Pharmaceuticals,Inc. | 87ef9aa6-2faa-0f77-e053-2a95a90a3a26 | 2024-06-14 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol | METOPROLOL TARTRATE | Baxter Healthcare Corporation | 09566368-f91d-43a3-b683-30c844fb125a | 2024-05-13 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Rising Pharma Holdings, Inc. | 30b2b576-4939-4903-be59-dbd1624a5eb6 | 2024-04-05 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Golden State Medical Supply, Inc. | bec7ccad-00ad-4a3b-e053-2995a90ae3d8 | 2024-03-18 | Warnings, Adverse reactions | W5S57Y3A5L |
| METOPROLOL TARTRATE | METOPROLOL TARTRATE | HF Acquisition Co LLC, DBA HealthFirst | 99b22be0-d2b4-2449-e053-2995a90a6c28 | 2024-02-22 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Aurobindo Pharma Limited | ac4ac150-d3e6-4bd1-8a4a-7d63fade3e49 | 2024-02-13 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Aurobindo Pharma Limited | 2b705cb6-cb75-4c2a-907a-4bd45d18bc2c | 2024-02-13 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Mylan Pharmaceuticals Inc. | 809c6386-0039-42ff-a03e-e42733e229b8 | 2024-01-31 | Warnings, Adverse reactions | W5S57Y3A5L |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | 2b77f66f-6891-4977-be8f-7955473d2f92 | 2024-01-04 | Warnings, Adverse reactions | W5S57Y3A5L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.